Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	6 Months Ended
	Jul. 30, 2011	Jul. 31, 2010
Cash flows from operating activities:
Net loss	$ (68,288)	$ (57,272)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	50,734	52,740
Amortization of lease-related interests	2,389	2,293
Share-based compensation expense	2,639	3,406
(Gain) loss on sale of property, fixtures and equipment	(58)	151
Reclassifications of other comprehensive loss	2,211	3,906
Loss on extinguishment of debt	9,450
Amortization of deferred financing costs	4,301	4,622
Amortization of deferred gain on sale of proprietary credit card portfolio	(1,207)	(1,207)
Deferred income tax (benefit) provision	(2,386)	810
Changes in operating assets and liabilities:
Increase in merchandise inventories	(6,554)	(16,237)
Decrease in prepaid expenses and other current assets	8,469	18,588
Decrease in other long-term assets	589	3,569
Increase in accounts payable	65,373	54,141
Decrease in accrued payroll and benefits and accrued expenses	(32,226)	(22,552)
Increase in income taxes payable	367	193
Increase (decrease) in other long-term liabilities	3,418	(1,969)
Net cash provided by operating activities	39,221	45,182
Cash flows from investing activities:
Capital expenditures	(26,666)	(20,105)
Proceeds from sale of property, fixtures and equipment	134	23
Net cash used in investing activities	(26,532)	(20,082)
Cash flows from financing activities:
Payments on long-term debt and capital lease obligations	(342,157)	(305,395)
Proceeds from issuance of long-term debt	348,398	280,094
Cash dividends paid	(947)
Restricted shares forfeited in lieu of payroll taxes	(3,584)	(4,082)
Proceeds from stock options exercised	385
Deferred financing costs paid	(5,869)	(714)
(Decrease) increase in book overdraft balances	(11,805)	1,357
Net cash used in financing activities	(15,579)	(28,740)
Net decrease in cash and cash equivalents	(2,890)	(3,640)
Cash and cash equivalents at beginning of period	16,339	18,922
Cash and cash equivalents at end of period	$ 13,449	$ 15,282